The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptors
Open accessAbstract
This paper describes the pharmacology of the novel 5‐hydroxytryptamine 3 (5‐HT3) receptor antagonist GR38032F. On the isolated vagus nerve and superior cervical ganglion of the rat, R,S‐GR38032F behaved as a reversible competitive antagonist of 5‐HT‐induced depolarization with pK B values of 8.61 ± 0.08 (n = 19) and 8.13 ± 0.07 (n = 16), respectively. The resolved R‐ and S‐isomers of GR38032F were approximately equipotent as 5‐HT antagonists on the rat vagus nerve: the pK B values were 8.95 ± 0.05 (n = 16) and 8.63 ± 0.08 (n = 17), respectively. R,S‐GR38032F was also an effective antagonist of 5‐HT on the rabbit isolated vagus nerve: in this case the pK B value was 9.40 ±0.14 (n = 4). On the rabbit isolated heart, low concentrations of R,S‐GR38032F (3 × −10 11 −1 × 10‐9 m) antagonized the positive chronotropic effect of 5‐HT and 2‐methyl‐5‐hydroxytryptamine (2‐methyl‐5‐HT). However, the effects of the compound did not appear consistent with simple reversible competition. On the longitudinal smooth muscle of the guinea‐pig ileum, R,S‐GR38032F caused concentration‐dependent parallel rightward displacement of the 2‐methyl‐5‐HT concentration‐contraction response curve; in contrast, a portion of the response to 5‐HT appeared resistant to R,S‐GR38032F. pK B values estimated from the effects of the compound against 2‐methyl‐5‐HT or the inhibitable portion of the response to 5‐HT were 7.31 ± 0.06 (n = 8) and 7.33 ± 0.13 (n = 8), respectively. Against 2‐methyl‐5‐HT, R‐GR38032F seemed more potent (pK B 7.20 ± 0.10; n = 6) than S‐GR38032F (pK B 6.30 ± 0.05; n = 6). R,S‐GR38032F is highly selective for 5‐HT3 receptors, and at concentrations of 3 × 10−6‐3 × 10−5m, had negligible agonist or antagonist activity on other 5‐HT or non‐5‐HT receptor‐containing tissues on which it was tested. The potency and duration of action of R,S‐GR38032F in blocking 5‐HT 3 receptors in vivo were assessed by measuring its ability to antagonize the bradycardic response to 5‐HT or 2‐methyl‐5‐HT administered intravenously (i.v.) to anaesthetized animals. For i.v. administration to the rat, the ED 50 for R,S‐GR38032F against 2‐methyl‐5‐HT (100 μg kg−1) was 0.4 (95% confidence limits 0.18–0.87) μg kg−1 (n = 10); the corresponding value for oral administration to this species was 7.0 (3.0–22.0) μg kg−1 (n = 8–10 per dose level). R,S‐GR38032F was similarly effective in the anaesthetized cat. The present results are discussed with reference to the postulated existence of subtypes of the 5‐HT3 receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SOME QUANTITATIVE USES OF DRUG ANTAGONISTS
ARUNLAKSHANA, O., & SCHILD, H. O. (1959) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1959.tb00928.x · Cited by 3,938
Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine
Bradley, P. B., Engel, G., Feniuk, W., Fozard, J. R., Humphrey, P. P. A., Middlemiss, D. N., Mylecharane, E. J., Richardson, B. P., & Saxena, P. R. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90207-8 · Cited by 1,258
TWO KINDS OF TRYPTAMINE RECEPTOR
GADDUM, J. H., & PICARELLI, Z. P. (1957) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1957.tb00142.x · Cited by 847
Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs
Richardson, B. P., Engel, G., Donatsch, P., & Stadler, P. A. (1985) · Nature · doi:10.1038/316126a0 · Cited by 840
pA, A NEW SCALE FOR THE MEASUREMENT OF DRUG ANTAGONISM
SCHILD, H. O. (1947) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1947.tb00336.x · Cited by 754
MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors
Fozard, J. R. (1984) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/bf00518776 · Cited by 429
The rat anococcygeus muscle and its response to nerve stimulation and to some drugs
GILLESPIE, J. S. (1972) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1972.tb08097.x · Cited by 360
The potential anxiolytic activity of GR38032F, a 5‐HT3‐receptor antagonist
Jones, B. J., Costall, B., Domeney, A. M., Kelly, M. E., Naylor, R. J., Oakley, N. R., & Tyers, M. B. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11489.x · Cited by 327
Self-citationIreland, S. J., & Tyers, M. B. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb16844.x · Cited by 278
Self-citationRECEPTORS FOR 5‐HYDROXYTRYPTAMINE AND NORADRENALINE IN RABBIT ISOLATED EAR ARTERY AND AORTA
Apperley, E., Humphrey, P. P. A., & Levy, G. (1976) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1976.tb10398.x · Cited by 197
Cited by
Shepherd, J. K., Grewal, S. S., Fletcher, A., Bill, D. J., & Dourish, C. T. (1994) · Psychopharmacology · doi:10.1007/bf02244871 · Cited by 739
Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
Gralla, R. J., Osoba, D., Kris, M. G., Kirkbride, P., Hesketh, P. J., Chinnery, L. W., Clark-Snow, R., Gill, D. P., Groshen, S., Grunberg, S., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2971 · Cited by 664
Marty, M., Pouillart, P., Scholl, S., Droz, J. P., Azab, M., Brion, N., Pujade-Lauraine, E., Paule, B., Paes, D., & Bons, J. (1990) · New England Journal of Medicine · doi:10.1056/nejm199003223221205 · Cited by 406
Gaba, M., & Mohan, C. (2016) · Medicinal Chemistry Research · doi:10.1007/s00044-015-1495-5 · Cited by 366
The potential anxiolytic activity of GR38032F, a 5‐HT3‐receptor antagonist
Jones, B. J., Costall, B., Domeney, A. M., Kelly, M. E., Naylor, R. J., Oakley, N. R., & Tyers, M. B. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11489.x · Cited by 327
Self-citation
Metadata
- Authors
- Butler, A., Hill, J. M., Ireland, S. J., Jordan, C. C., & Tyers, M. B.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1988-06
- Volume
- 94
- Issue
- 2
- Pages
- 397-412
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2010163969
- Cited by
- 374
- References
- 17
- FWCI
- 12.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptors. https://app.cochat.ai/papers/10.1111/j.1476-5381.1988.tb11542.x
- The paper
- Butler, A., Hill, J. M., Ireland, S. J., Jordan, C. C., & Tyers, M. B. (1988). Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptors. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1988.tb11542.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.